Eton Pharmaceuticals, Inc. Annual Amortization of Intangible Assets in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Eton Pharmaceuticals, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2019 to 2023.
  • Eton Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $267K, a 46.7% increase year-over-year.
  • Eton Pharmaceuticals, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $1M, a 50.6% decline year-over-year.
  • Eton Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2023 was $790K, a 51.1% decline from 2022.
  • Eton Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2022 was $1.62M, a 693% increase from 2021.
  • Eton Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2021 was $204K, a 36% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $790K -$827K -51.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $1.62M +$1.41M +693% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $204K +$54K +36% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $150K +$125K +500% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $25K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.